US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 23.9400
  • +0.6100+2.61%
Close Feb 14 16:00 ET
  • 23.9400
  • 0.00000.00%
Post 20:01 ET
262.03MMarket Cap-1.03P/E (TTM)

About Cidara Therapeutics Company

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolCDTX
Company NameCidara Therapeutics
Listing DateApr 15, 2015
Issue Price16.00
Founded2012
CEODr. Jeffrey Stein, PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address6310 Nancy Ridge Drive,Suite 101
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-752-6170

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeffrey Stein, PhD
  • Director, President and Chief Executive Officer
  • 1.56M
  • Dr. Preetam Shah, M.B.A.,PhD
  • Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
  • --
  • Leslie Tari
  • Chief Scientific Officer
  • --
  • Shane M. Ward
  • Chief Operating Officer, Chief Legal Officer and Corporate Secretary
  • 929.86K
  • Daniel D. Burgess
  • Chairman of the Board
  • 126.84K
  • Dr. Josh Resnick, M.D.
  • Director
  • --
  • Dr. James Merson, PhD
  • Director
  • --
  • Ryan Spencer
  • Director
  • --
  • Carin Canale-Theakston
  • Independent Director
  • 82.34K
  • Theodore R. Schroeder
  • Independent Director
  • 98.84K
  • Chrysa Mineo
  • Independent Director
  • 91.34K
  • Dr. Bonnie L. Bassler, PhD
  • Independent Director
  • 86.84K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More